Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,918

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

for

Crohn's Disease

Location: Southlake TX, Katy TX, Flowood MS, Glenview IL,

Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06637631

Phase2, Recruiting

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

for

Colitis Ulcerative

Location: Southlake TX, Katy TX, Lubbock TX, Glenview IL,

Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06867094

Phase2, Recruiting

FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

for

Implant Based Breast Reconstruction

Location: Fort Worth TX

Sponsor: Musculoskeletal Transplant Foundation

Sex: Female

Age: 22+

Code: NCT06797258

Recruiting

Active & Responsive

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for

Major Depressive Disorder

Location: DeSoto TX, Wichita Falls TX, Austin TX,

Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase2, Recruiting

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

for

Major Depressive Disorder (MDD)

Location: Richardson TX, DeSoto TX, Wichita Falls TX, Austin TX,

Sponsor: Draig Therapeutics Ltd

Sex: All

Age: 18 - 70+

Code: NCT07300969

Phase2, Recruiting

Active & Responsive

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

for

Transverse Myelitis

Location: Dallas TX

Sponsor: Q Therapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT03887273

Phase1, Phase2, Recruiting

Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for

Advanced Solid Tumor

Location: Irving TX, Tyler TX, Houston TX, San Antonio TX,

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

for

Transthyretin (TTR) Amyloid Cardiomyopathy

Location: Dallas TX

Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 30 - 70+

Code: NCT07196839

Recruiting

Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for

Crohn's Disease

Location: Mansfield TX, Tyler TX, Oklahoma City OK, Cedar Park TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting

Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for

Solid Tumors Harboring MET Amplification

Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,

Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting

Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for

Chronic Lymphocytic Leukemia

Location: Dallas TX, Austin TX, Tulsa OK, Kansas City MO,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting

Featured

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

for

Primary Open Angle Glaucoma

Location: Dallas TX, Oklahoma City OK, Houston TX, New Orleans LA,

Sponsor: AbbVie

Sex: All

Age: 45+

Code: NCT06822738

Phase3, Recruiting

Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for

Non-Small Cell Lung Cancer,

Location: Irving TX, Austin TX, Houston TX, San Antonio TX,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting

FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for

Generalized Anxiety Disorder (GAD)

Location: Dallas TX, Wichita Falls TX, Oklahoma City OK,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting

FeaturedActive & Responsive

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

for

Bipolar I or II Disorder

Location: Dallas TX, DeSoto TX, Oklahoma City OK,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07220460

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for

Bipolar I Disorder, Bipolar II Disorder

Location: Richardson TX, Oklahoma City OK, Austin TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for

Major Depressive Disorder

Location: Richardson TX, Oklahoma City OK, Austin TX, Bellaire TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase2, Recruiting

FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for

Hypothyroidism

Location: Irving TX, Dallas TX, Fort Worth TX, Mesquite TX,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

FeaturedActive & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for

Rheumatoid Arthritis

Location: Carrollton TX, Plano TX, Allen TX, Mesquite TX,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase2, Recruiting

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

for

Active Rheumatoid Arthritis

Location: Red Oak TX, Tomball TX, Lake Charles LA, Baytown TX,

Sponsor: Elevara Medicines Limited

Sex: All

Age: 18 - 70+

Code: NCT07409103

Phase2, Recruiting

Paid Clinical Trials Denton

Filter results

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Interested in new trials?

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

A Study of YL201 in Patients With Advanced Solid Tumors

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)